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Glucosinolates are natural products characteristic of the Brassicales order, which include 
vegetables such as cabbages and the model plant Arabidopsis thaliana. Glucoraphanin 
is the major glucosinolate in broccoli and associated with the health-promoting effects 
of broccoli consumption. Toward our goal of creating a rich source of glucoraphanin for 
dietary supplements, we have previously reported the feasibility of engineering glucora-
phanin in Nicotiana benthamiana through transient expression of glucoraphanin biosyn-
thetic genes from A. thaliana (Mikkelsen et al., 2010). As side-products, we obtained 
fivefold to eightfold higher levels of chain-elongated leucine-derived glucosinolates, 
not found in the native plant. Here, we investigated two different strategies to improve 
engineering of the methionine chain elongation part of the glucoraphanin pathway in 
N. benthamiana: (1) coexpression of the large subunit (LSU1) of the heterodimeric iso-
propylmalate isomerase and (2) coexpression of BAT5 transporter for efficient transfer of 
intermediates across the chloroplast membrane. We succeeded in raising dihomome-
thionine (DHM) levels to a maximum of 432 nmol g−1 fresh weight that is equivalent to a 
ninefold increase compared to the highest production of this intermediate, as previously 
reported (Mikkelsen et  al., 2010). The increased DHM production without increasing 
leucine-derived side-product levels provides new metabolic engineering strategies for 
improved glucoraphanin production in a heterologous host.
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inTrODUcTiOn
Plants are the source of an immense diversity of natural compounds, many of which are of high 
value as medicine or health-promoting agents. Often these compounds are difficult or impossible to 
produce by chemical synthesis, and extraction from plants is the only source.
Epidemiological studies strongly indicate that dietary consumption of cruciferous vegetables 
(e.g., broccoli) is correlated with reduced risk of the developing cancer (Verkerk et al., 2009). These 
and other health-promoting effects have been associated with glucosinolates, natural products 
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FigUre 1 | Biosynthetic pathway of dihomomethionine and glucoraphanin in Arabidopsis. Glucoraphanin biosynthesis consists of three steps: methionine 
conversion to dihomomethionine (DHM) by two cycles in the chain elongation machinery. Followed by DHM conversion into 4-methylthiobutyl glucosinolate (4MTOB) 
by the core structure pathway, and finally conversion of 4MTOB into 4-methylsulfinyl GLS (4MSOB), commonly known as glucoraphanin. Structures for 
intermediates of methionine chain elongation are depicted with DHM as the desired intermediate for the formation of glucoraphanin. αKA = α-keto acid, methylthio 
malate intermediates after condensation (1) and after isomerization (2). n = number of additional methylene groups in the methionine side chain as a result of the 
condensation reaction in the chain elongation cycle: n = 1 for methionine, n = 2 and n = 3 for intermediates from the first and second side-chain elongation cycle, 
respectively.
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characteristic to the Brassicales order, which include vegetables 
such as broccoli and cabbages and the model plant Arabidopsis 
thaliana (Halkier and Gershenzon, 2006).
Substantial attention has been given to particularly the glucosi-
nolate glucoraphanin that is present in broccoli, as it is generally 
thought to be the major bioactive compound associated with the 
cancer-preventive effects of broccoli (Traka and Mithen, 2009; 
Kensler et al., 2013). A recent human intervention study showed 
that diets with glucoraphanin-enriched broccoli resulted in retun-
ing of cellular processes in the mitochondria to a basal level that is 
critical for maintaining a healthy metabolic balance (Armah et al., 
2013). The health-promoting effects have resulted in a strong 
desire to increase the intake of glucoraphanin. The current market 
is based on products with unreliable amounts of glucoraphanin, if 
any at all. The latter has primed an interest to engineer the produc-
tion of glucoraphanin into a heterologous host to obtain a stable, 
rich source of this product and enable intake of well-defined doses 
for dietary and pharmaceutical applications.
As a prerequisite for pathway engineering, all glucoraphanin 
biosynthetic genes have been identified in the model plant A. 
thaliana (Sonderby et al., 2010). Previously, we have engineered 
the six glucosinolate core pathway genes of simple indolyl- and 
benzyl glucosinolate-derived directly from the protein amino 
acids tryptophan and phenylalanine into the non-cruciferous 
plant Nicotiana benthamiana (Geu-Flores et al., 2009; Pfalz et al., 
2011), and for indolylglucosinolates also into yeast (Mikkelsen 
et al., 2012). Engineering of the complex glucoraphanin pathway 
presents additional challenges as it consists of 12 biosynthetic 
enzymes, which are partitioned between the chloroplast and the 
cytosol (Halkier and Gershenzon, 2006; Sonderby et al., 2010).
Briefly, biosynthesis of glucoraphanin can be divided into 
three major parts (Figure 1). First, methionine is transaminated 
into a α-keto acid (α-KA) by a cytosolic branched-chain ami-
notransferase (BCAT4) (Schuster et  al., 2006). This α-KA then 
enters the chloroplast where it undergoes side-chain elongation. 
The carbon side chain is elongated by a condensation reaction 
catalyzed by methylthioalkylmalate synthase (MAM) (Textor 
et  al., 2004), followed by isomerization and oxidative decar-
boxylation catalyzed by an isopropylmalate isomerase (IPMI) 
and an isopropylmalate dehydrogenase (IPMDH), respectively 
(He et al., 2010, 2011). Following two cycles of chain elongation 
dihomomethionine (DHM) is formed, which subsequently is 
converted by the cytosolic, ER-associated core structure pathway 
to 4-methylthiobutyl (4MTOB) glucosinolate (GLS) (Figure 1), 
which finally is S-oxygenated to 4-methylsulfinylbutyl (4MSOB) 
glucosinolate, commonly known as glucoraphanin (Figure  1) 
(Sonderby et al., 2010).
The feasibility of metabolic engineering the complex gluc-
oraphanin pathway was recently shown by transient expression 
of 10 biosynthetic genes in N. benthamiana (Mikkelsen et  al., 
2010). Though formation of ~50 nmol g−1 fresh weight (fw) of 
the chain-elongated methionine-derived glucoraphanin was 
detected, fivefold to eightfold more of chain-elongated leucine-
derived glucosinolates were detected. The latter does not accu-
mulate in the native Arabidopsis but have been observed under 
conditions when MAM3 in the methionine chain elongation 
pathway was overexpressed using the 35S promoter (Field et al., 
2004). Evolutionarily, the recursive methionine chain elongation 
pathway has evolved from the non-recursive valine to leucine 
chain elongation pathway in primary metabolism (Field et  al., 
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2004; Textor et al., 2004; Schuster et al., 2006; Binder et al., 2007; 
He et  al., 2010; de Kraker and Gershenzon, 2011). The ability 
to accumulate chain-elongated leucine-derived glucosinolates 
upon engineering in tobacco supports the proposed promiscuity 
of enzymes in specialized metabolism compared with those in 
primary metabolism (Weng and Noel, 2012). It also indicates 
that the native plant has evolved mechanism(s) to prevent the 
formation of these leucine-derived side-products.
Homologs are described for all genes in methionine chain 
elongation. Coexpression analysis and knockout mutants have 
helped to identify specific roles of the different homologs. 
MAM1 was identified as the enzyme catalyzing two condensa-
tion reactions (Textor et al., 2004). For IPMDH, three homologs 
are known of which IPMDH1 was recently reported to be the 
best candidate for methionine chain elongation, whereas 
IPMDH2 and IPMDH3 were involved in leucine biosynthesis 
(LeuC) (He et  al., 2009, 2011, 2013). Nevertheless, IPMDH3 
was previously shown to be functional in metabolic engineering 
of DHM (Mikkelsen et  al., 2010). The isomerization reaction 
catalyzed by IPMI has yet another level of complexity. IPMI 
is a heterodimeric enzyme consisting of a single large subunit 
(LSU1) that forms a catalytic active enzyme with either of 
three small subunits (SSU1/2/3). The small subunits define in 
which pathway IPMI is active. SSU2 and SSU3 are generally 
associated with methionine chain elongation and SSU1 with 
LeuC (He et  al., 2010). Nevertheless, it was recently hypoth-
esized that SSU1 was actively involved in the first two cycles 
of methionine chain elongation (Imhof et al., 2014). Transport 
of α-keto acids (formed initially by cytosolic BCAT4 and after 
each cycle by the chloroplastic IPMDH enzyme) across the 
chloroplast membranes was suggested to be performed by the 
bile acid transporter 5 (BAT5) (Gigolashvili et al., 2009). This 
was based on bat5 knockout mutants showing a 50% reduction 
in methionine-derived, aliphatic glucosinolates and transport of 
α-keto acids into the chloroplast was impaired.
Toward our goal to establish high glucoraphanin production 
in a heterologous host, optimization of DHM production is 
essential. General means to enhance product formation in path-
way engineering projects include screening for lacking enzymes, 
enzymes with improved properties (i.e., substrate specificity, 
kinetics), alleviating catalytic bottlenecks and increasing flux 
through the pathway, and taking compartmentalization into 
account (Heinig et  al., 2013). Here, we report optimization of 
the production of the glucoraphanin precursor DHM in N. 
benthamiana. As reference for comparison, we use the highest-
producing gene combination, as previously reported. The increase 
is obtained by optimizing the combination of biosynthetic genes 
used. Moreover, we provide additional evidence that BAT5 is the 
transporter for α-keto acids across the chloroplast membrane 
system.
MaTerials anD MeThODs
Plant Material
Nicotiana benthamiana plants were grown in small pots of 5.5 cm 
diameter in a green house at 24°C (day) and 18°C (night) with 
50–60% humidity for ~3–4 weeks (to four to six leaves stage).
cloning and Transformation
All genes were cloned into a USER compatible version of pCam-
bia33001 plasmid by USER cloning (Nour-Eldin et  al., 2006; 
Bitinaite et  al., 2007; Geu-Flores et  al., 2007). In brief, coding 
sequences of individual genes were amplified with single Uracil 
containing primers that were compatible with the USER ready-
made plasmid. For PCR primers, see Table S1 in Supplementary 
Material. PCR products were purified (QIAquick PCR Purification 
Kit, Qiagen, Hilden, Germany), and 1–5 μL of purified PCR prod-
uct were subsequently mixed with 1 μL of plasmid. The volume 
was adjusted to 10 μL and after addition of 1 μL USER Enzyme 
(NEB, Ipswich, MA, USA), the mix was incubated at 37 and 
25°C for 30 min each. Two microliters of the USER cloning mix 
were added to 60 μl of chemical competent E. coli DHB10 (NEB, 
Ipswich, MA, USA) cells by heat shock. Briefly, 10 min on ice, 90 s 
42°C followed by 2 min on ice. Cells were incubated for 60 min 
at 37°C after addition of 250 μL LB media. Subsequently, 100 μL 
were plated on LB agar plates containing kanamycin (50 μg mL−1). 
Correct gene insertions were verified by sequencing (Macrogen 
Europe, Amsterdam, Netherlands). Constructs with correct 
insertions were subsequently transformed into Agrobacterium 
tumefaciens strain pGV3850 by electroporation (2 mm cuvette, 
2.5  kV, 400 Ω, and 25 μF) in a Bio-Rad GenePulser (Bio-Rad, 
Hercules, CA, USA). One milliliter YEP media was added, and 
cells were incubated for 3 h at 28°C with shaking. Subsequently, 
150  μL were plated on YEP agar plates containing antibiotics 
(30 μg mL−1 rifampicin and 50 μg mL−1 kanamycin).
Transient expression by infiltration of 
Nicotiana benthamiana
Overnight cultures of A. tumefaciens carrying the different 
gene constructs were grown in 10  mL YEP media (containing 
50 μg mL−1 kanamycin and 30 μg mL−1 rifampicin) at 28°C and 
220 rpm. Overnight cultures were harvested by centrifugation at 
20°C for 15 min at 4500 × g. The cell pellets were resuspended in 
infiltration buffer (10 mM MgCl2, 10 mM MES, pH 5.6) containing 
100 μM acetosyringone (3,5-dimethoxy-4-hydroxyacetophenone, 
Sigma-Aldrich, Steinheim, Germany) and shaken at 150 rpm for 
1–2 h at room temperature prior to plant infiltration. Cell densi-
ties for all cultures was adjusted to OD600 ≈  0.21–0.25, which 
resulted in a final concentration for each individual construct of 
OD600 ≈ 0.03 for experiments with chain elongation enzymes only 
and OD600 ≈ 0.015 for experiments, which included chain elonga-
tion and core structure enzymes. These low OD were sufficient 
to ensure efficient transformation while keeping the stress levels 
for N. benthamiana leaves low. In all experiments, the suppressor 
protein p19 was included to reduce silencing effects (Voinnet 
et al., 2003). For each individual, experiment two to three leaves of 
four N. benthamiana plants (3–4 weeks old) were infiltrated with 
the different combinations of A. tumefaciens cultures harboring 
the different gene constructs. A maximum of seven different A. 
tumefaciens cultures were mixed. The volume of combinations 
with fewer than seven constructs was adjusted by addition of the 
respective amount of infiltration buffer.
1 http://www.cambia.org/
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Plant Material harvesting and sample 
Preparation
Plant material was harvested 5  days after infiltration with A. 
tumefaciens. From each leaf, four leaf disks of 1 cm diameter were 
harvested from infiltrated areas and weighed. Amino acids were 
extracted with 400 μL of 85% methanol containing norleucine 
(10 μM) as internal standard (IS). Amino acid concentrations 
were determined by comparison to 13C,15N-labeled algal amino 
acids described below.
amino acid analysis by lc-Ms
The resulting extract was diluted in a ratio of 1:10 (v:v) in 
water containing the 13C,15N-labeled amino acid mix (Isotec, 
Miamisburg, OH, USA). Amino acids in the diluted extracts 
were directly analyzed by LC-MS/MS. The analysis method 
was modified from a protocol described by Jander et  al. 
(2004). Chromatography was performed on an Agilent 1200 
HPLC system (Agilent Technologies, Boeblingen, Germany). 
Separation was achieved on a Zorbax Eclipse XDB-C18 column 
(50  mm ×  4.6  mm, 1.8  μm, Agilent Technologies, Germany). 
Formic acid (0.05%) in water and acetonitrile were employed 
as mobile phases A and B, respectively. The elution profile was 
0–1 min, 3% B in A; 1–2.7 min, 3–100% B in A; 2.7–3 min 100% 
B, 3.1–6 min 3% B in A. The mobile phase flow rate was 1.1 mL/
min. The column temperature was maintained at 25°C. The 
liquid chromatography was coupled to an API 5000 tandem mass 
spectrometer (AB Sciex, Darmstadt, Germany) equipped with a 
Turbospray ion source operated in positive ionization mode. The 
instrument parameters were optimized by infusion experiments 
with pure standards (amino acid standard mix, Fluka, St. Louis, 
MO, USA). The ionspray voltage was maintained at 5500 eV. The 
turbo gas temperature was set at 700°C. Nebulizing gas was set 
at 70 psi, curtain gas at 35 psi, heating gas at 70 psi, and collision 
gas at 2  psi. Multiple reaction monitoring (MRM) was used to 
monitor analyte parent ion → product ion: MRMs were chosen as 
in Jander et al. (2004) except for Arg (m/z 175 → 70) and Lys (m/z 
147 → 84). In addition, MRMs for homomethionine (HM, m/z 
164 → 118), DHM (m/z 178 → 132), and S-adenosylmethionine 
(SAM, m/z 399 →  136). The chain-elongated leucine products 
homo-leucine (HL, m/z 146  →  100), dihomo-leucine (DHL, 
m/z 160 →  114), and trihomo-leucine (THL, m/z 174 →  128) 
were also monitored, but exact quantification was not possible 
for DHL and THL due to lack of reference standards. Values for 
DHL and THL are calculated based on the assumption of an equal 
response factor of 1 compared to 13C,15N-labeled phenylalanine 
due to their similar behavior in fragmentation and ionization 
compared to leucine and HL. Detailed values for mass transitions 
can be found in Table S2 in Supplementary Material. Both Q1 
and Q3 quadrupoles were maintained at unit resolution. Analyst 
1.5 software (AB Sciex, Darmstadt, Germany) was used for data 
acquisition and processing. Linearity in ionization efficiencies 
were verified by analyzing dilution series of standard mixtures 
(amino acid standard mix, Fluka + Gln, Asn, and Trp, also Fluka). 
All samples were spiked with 13C,15N-labeled amino acids (algal 
amino acids 13C,15N, Isotec, Miamisburg, OH, USA) at a concen-
tration of 10 μg of the mix per milliliter. The concentration of the 
individual labeled amino acids in the mix had been determined by 
classical HPLC–fluorescence detection analysis after pre-column 
derivatization with ortho-phthalaldehyde-mercaptoethanol 
using external standard curves made from standard mixtures 
(amino acid standard mix, Fluka + Gln, Asn, and Trp, also Fluka). 
Individual amino acids in the sample were quantified by the 
respective 13C,15N-labeled amino acid IS, except for tryptophan, 
and asparagin: tryptophan was quantified using 13C,15N-Phe 
applying a response factor of 0.42, asparagin was quantified using 
13C,15N-Asp applying a response factor of 1.0.
statistical analysis
Statistical analysis was performed with the SigmaPlot 12.0 statis-
tics package (Systat Software, San Jose, CA, USA).
accession numbers
Sequence data from this article can be found via the TAIR 
database2 under the AGI locus identifiers: BCAT4 (At3g19710), 
RBSC1A (At1g67090), BAT5 (At4g12030), MAM1 (At5g23010), 
IPMI-LSU1 (AT4g13430), IPMI-SSU1 (At2g43090), IPMI-SSU2 
(At2g43100), IPMI-SSU3 (At3g58990), IPMDH1 (At5g14200), 
and IPMDH3 (At1g31180).
resUlTs anD DiscUssiOn
In this study, we identified a new combination of genes for 
methionine chain elongation that produced the highest level of 
DHM in N. benthamiana. Additionally, we measured how these 
optimizations affected the formation of chain-elongated leucine-
derived side-products.
Definition of a reference Value for 
Optimization of DhM Production
Toward our goal of optimizing DHM production by transient 
expression experiments in N. benthamiana, we choose as refer-
ence a gene combination identical the highest-producing gene 
combination, as previously reported (Mikkelsen et  al., 2010). 
In this study, genes were expressed from multi-gene constructs 
with two or three genes separated by 2A sequences (Mikkelsen 
et al., 2010). However, as we in the current study would compare 
multiple gene combinations, we expressed all genes from single 
gene constructs as this enabled us to freely combine individual 
genes. The previously reported gene combination for highest 
DHM production included a chloroplast-localized BCAT4 
together with MAM1, IMPI–SSU3, and IPMDH3 and resulted in 
the formation of 51.4 ± 20.8 nmol g−1 fw (Mikkelsen et al., 2010). 
When we expressed the same genes individually, we obtained 
only 14.6 ± 4.4 nmol g−1 fw, which was used as reference value 
in this study (Table 1; Figures 2A and 3A). Several parameters 
can account for the discrepancy between the values published by 
Mikkelsen et al. (2010) and the present study. Using single gene 
constructs increases the number of Agrobacterium strains that 
need to be mixed for coexpression. It has also been reported that 
2 http://www.arabidopsis.org
FigUre 2 | comparison of production of DhM and chain-elongated 
leucine-derived products. (a) DHM levels. (B) Levels of homo-leucine (HL), 
dihomo-leucine (DHL), and trihomo-leucine (THL). BCAT4 is relocalized to the 
chloroplast (chl BCAT4) in combinations A1–A3. The transporter protein 
BAT5 is coexpressed in combinations A5–A8 and the large subunit (LSU1) of 
IPMI is coexpressed in all combinations except A1. Ctrl represents 
non-infiltrated. Chl BCAT4 = BCAT4 with signal peptide for relocation to 
chloroplast, +LSU1 = combinations where LSU1 was coexpressed, and 
+BAT5 = combinations where BAT5 was coexpressed. Data are represented 
as mean ± SEM in nanomole per gram fresh weight (N = 8).
TaBle 1 | Optimization of DhM production in N. benthamiana.
combination genes DhM
A1 = Referencea chlBCAT4, MAM1, SSU3, IPMDH3 14.6 (±4.4)
A2 chlBCAT4, MAM1, LSU1, SSU3, IPMDH3 312.6 (±40.2)
A3 chlBCAT4, MAM1, LSU1, SSU3, IPMDH1 228.5 (±23.5)
A4 BCAT4, MAM1, LSU1, SSU3, IPMDH1 41.9 (±9.2)
A5 BCAT4, BAT5, MAM1, LSU1, SSU3, 
IPMDH1
315.0 (±54.8)
A6 BCAT4, BAT5, MAM1, LSU1, SSU1, 
IPMDH1
340.6 (±86.5)
A7 BCAT4, BAT5, MAM1, LSU1, SSU2, 
IPMDH1
432.2 (±70.8)
A8 BCAT4, BAT5, MAM1, LSU1, SSU1, 
SSU3, IPMDH1
400.4 (±37.3)
Ctrl Non-infiltrated n.d.
Data are represented as mean ± SEM in nanomole per gram fresh weight (N = 8).
DHM, dihomomethionine; fw, fresh weight; chl, chloroplastic signal peptide; BCAT4, 
branched-chain aminotransferase 4; MAM1, methylthioalkylmalate synthase 1; LSU1, 
large subunit of isopropylmalate isomerase (IPMI); SSU, small subunit of IPMI; IPMDH, 
isopropylmalate dehydrogenase; Ctrl, control.
aReference to highest-producing gene combination previously reported (Mikkelsen 
et al., 2010) with 51.4 nmol DHM g−1 fw. For values of all amino acids, see also Table 
S3 in Supplementary Material.
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constructs containing 2A sequences for self-processing of multi-
gene constructs can result in incomplete cleavage and formation 
of fusion proteins, which can influence the outcome of metabolic 
engineering from transient expression in plants (Burén et  al., 
2012). Other potential reasons include differences in growth 
conditions for the tobacco plants and differences in detection and 
quantification of the individual compounds by LC-MS between 
the two studies. In combination, the experimental and technical 
differences do not allow for a direct comparison of the DHM 
production. All calculations are based on the DHM amounts 
produced in the reference gene combination of the present study, 
which previously resulted in the highest DHM production.
coexpression of Arabidopsis IPMI-LSU1 is 
essential for efficient Formation of DhM 
by the Methionine chain elongation 
Pathway
In the heterodimeric isopropylmalate synthase (IPMI), the large 
subunit (LSU1) forms a functional enzyme with one of three 
small subunits (SSU1–3) catalyzing the isomerization step in the 
methionine and valine (to leucine) chain elongation machinery 
(Knill et  al., 2009). Previously, it was shown that endogenous 
LSU of tobacco was able to substitute for the A. thaliana LSU1 
(that was not included in the gene combination) and form a 
functional IPMI enzyme with A. thaliana SSUs that resulted in 
production of DHM (Mikkelsen et al., 2010). Here, we show that 
inclusion of Arabidopsis’ LSU1 in the gene combination resulted 
in a 21-fold increase of DHM production (Table 1; Figures 2A 
and 3A, combinations A1 and A2). Coexpression of A. thaliana 
LSU1 probably has alleviated a bottleneck and thus increased 
flux through the pathway. Another possibility could be better 
interaction between the two A. thaliana subunits in comparison 
to a heterodimer formed from N. benthamiana LSU and A. 
thaliana SSU. However, the high amino acid sequence identity 
of ~95% between A. thaliana LSU1 and Nicotiana sylvestris LSU, 
a close relative of N. benthamiana, suggests that functionality is 
not impaired. Recently, it was also demonstrated that A. thaliana 
SSUs to a certain extend can complement E. coli knockout mutants 
lacking the respective SSU homolog in LeuC (Imhof et al., 2014). 
Therefore, the increased production of DHM is most likely a 
result of a better ratio between large subunit to small subunit and 
the formation of a higher number of catalytically active IMPI 
heterodimers as a result of coexpressing LSU1 under the control 
of the same CaMV35S promoter as the other constructs.
choice of small subunit in iPMi has no 
significant influence on DhM Production
It has been reported that the three small subunits (SSU1/2/3) 
define in which pathway IPMI is active, with SSU2 and SSU3 
being associated with methionine chain elongation and SSU1 
with LeuC (He et al., 2010). More recently, it was hypothesized 
that SSU1 was active in the first two cycles of methionine chain 
elongation and that either SSU2 or SSU3 catalyzes the forma-
tion of the longer chain-elongated products (Imhof et al., 2014). 
Interestingly, we detected no significant difference in DHM 
FigUre 3 | graphical comparison of combinations with most significant increases in DhM production. (a) Nicotiana benthamiana LSU (NbLSU) can 
complement Arabidopsis IPMI small subunit (SSU3) into a functional heterodimer, and co-expression of Arabidopsis IPMI large subunit (LSU1) increased DHM 
production by 21-fold. (B) BAT5 is an efficient transporter for translocation of intermediates between the cytosolic BCAT4 and the chloroplast-localized part of 
methionine chain elongation and increased DHM production by 10-fold.
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production when we coexpressed the individual small subu-
nits of IPMI with the rest of the methionine chain elongation 
machinery (Table 1, combinations A5–A7). Furthermore, coex-
pression of SSU1 with SSU3 did not result in significantly higher 
production of DHM (Table 1, combination A8). Coexpression of 
SSU2 and SSU3 was previously shown to have no positive effect 
on DHM production (Mikkelsen et  al., 2010). Nevertheless, 
our data show that SSU1 has the ability to support the first two 
rounds of methionine chain elongation. At this point, it remains 
unclear if SSU1 catalyzes the first round(s) of methionine chain 
elongation in native A. thaliana plants and whether either SSU2 
or SSU3 catalyzes the formation of the longer chain-elongated 
products, as previously suggested (Imhof et al., 2014). A previ-
ously observed sevenfold difference in DHM production between 
coexpression of SSU2 and SSU3 (Mikkelsen et al., 2010) was not 
observed. This was insofar puzzling as differences in the present 
study were not as dramatic and not significant for the different 
products upon coexpression of either of the three SSUs together 
with LSU1 (Figure 2; Table 1, combinations A5–A7). One pos-
sible explanation could be that coexpression of IPMI–LSU1 has 
alleviated effects that might be related to functional differences 
between the three SSUs. And even though A. thaliana IPMI can 
complement E. coli mutant strains deficient for the respective 
homologs in LeuC (LeuC and LeuD) (He et al., 2010; Imhof et al., 
2014), it cannot be excluded that there are functional differences 
when catalyzing reactions in methionine chain elongation. 
Finally, it still remains unclear whether functional differences 
and the involvement of the different SSUs in either leucine 
biosynthesis or methionine chain elongation are the result of 
structural differences in the active sites or due to differences in 
temporal and spatial expression within different tissues in the 
plant (He et al., 2010; Imhof et al., 2014).
coexpression of the BaT5 Transporter 
Facilitates DhM Production with cytosolic 
BcaT4
Bile acid transporter 5 has been proposed to translocate sub-
strates and/or products of methionine chain elongation across the 
chloroplast membranes (Gigolashvili et al., 2009). The α-keto acid 
product of BCAT4 was proposed to be the substrate for import 
into the chloroplast by BAT5 as bat5 knockout mutants show 
50% reduced levels of aliphatic glucosinolates (including 4MSOB 
and 4MTB) and transport of α-keto acids into the chloroplast 
was impaired (Gigolashvili et al., 2009). As BAT5 may be critical 
for translocating the chain elongation products out of the chlo-
roplast, we investigated whether inclusion of BAT5 together with 
cytosolic BCAT4 improves DHM production.
In experiments where BCAT4 was expressed in the cytosol 
without coexpression of BAT5, a massive reduction in DHM pro-
duction to only 41.9 (±9.2) nmol g−1 fw was observed compared 
to chloroplast-localized BCAT4 (Table 1; Figures 2A and 3A). 
This demonstrates that although methionine chain elongation 
is a heterologous pathway, N. benthamiana still has the abil-
ity to transport α-keto acid intermediates at a low level. DHM 
production was fully restored upon coexpression of BAT5 with 
the cytosolic BCAT4 (Figure 3B). DHM levels were higher than 
in combinations with chloroplast-localized BCAT4, though not 
significantly higher (Table 1). It is not known whether cytosolic 
BCAT4 (or other chloroplast-localized BCATs) are involved in 
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transaminating the final chain-elongated methionine product, 
and whether a chain-elongated α-keto acid is substrate for export 
out of the chloroplast by BAT5. Nevertheless, the fact that DHM 
accumulated to such high levels indicated that BCAT4 may also 
transaminate the chain-elongated α-keto acids into the respective 
chain-elongated methionine and that BAT5 is an antiporter for 
the different chain-lengths α-keto acids.
Differences in DhM Production with 
iPMDh3 compared to iPMDh1
Three homologs exist for IPMDH, of which IPMDH3 was used 
for in the previous report for engineering DHM (Mikkelsen 
et al., 2010). A recent study linking association by coexpression 
suggested that IPMDH1 was the key player in methionine chain 
elongation while IPMDH2 and IPMDH3 were involved in LeuC 
(He et al., 2013). When we compared inclusion of IPMDH1 or 
IPMDH3 together with the other chain elongation genes, we 
observed that the production of DHM was always higher with 
IPMDH3 though never significantly higher (Table 1). The varia-
tion from transient expression in tobacco made it impossible to 
identify significant differences. Nevertheless, association by 
coexpression in Arabidopsis, as previously reported (He et  al., 
2013), does not exclude enzymatic promiscuity (Weng and Noel, 
2012) of the different IPMDH enzymes. This is also supported by 
the fact that there was no significant difference detected between 
the three IPMI small subunits (see above).
Presence of lsU1 has Major effects on 
Formation of leucine-Derived side-
Products but is independent of BcaT4 
localization
Previously, when the approximately fivefold to eightfold 
higher levels of leucine-derived glucosinolates were monitored 
(Mikkelsen et  al., 2010), it was not possible to differentiate if 
both leucine and isoleucine were taken as substrates by the 
chain elongation machinery. Here, we confirmed by UHPLC-MS 
analysis that only leucine and not isoleucine is taken as substrate 
(Mirza et al., 2016). Optimization of the gene combination for 
DHM production also affected the formation of chain-elongated 
leucine-derived products (Figure  2). Similar to DHM produc-
tion, chain-elongated leucine-derived products [homo-leucine 
(HL), dihomo-leucine (DHL), and the newly detected trihomo-
leucine (THL)] drastically increased by including LSU1 together 
with the other chain elongation genes (Figure 2). In contrast to 
DHM, leucine-derived products were formed in similar amounts 
independent of whether BCAT4 was expressed in the cytosol or 
the chloroplast, except for combination A1 where LSU1 was not 
coexpressed (Figure  2, combinations A1 and A4; Table S3 in 
Supplementary Material). Especially, the formation of DHL was 
higher when BCAT4 was localized to the chloroplast (Figure 2, 
combinations A2 and A3). Interestingly, formation of leucine-
derived products – especially the longer chain-elongated prod-
ucts DHL and THL – was reduced in the gene combination when 
SSU1 (A6) was coexpressed rather than SSU2 (A7) or SSU3 (A5) 
(Figure 2B). Also, THL was only found in combinations where 
LSU1 was coexpressed, which may be related to the overall lower 
production in this combination or a reduced ability of tobacco 
LSU to support three rounds of leucine chain elongation. THL 
had not been described previously as a side-product from engi-
neering of methionine chain elongation in tobacco (Mikkelsen 
et al., 2010) and neither from metabolic engineering of DHM in 
E. coli (Mirza et al., 2016).
increased DhM Formation considerably 
improves DhM to side-Product ratio
Increased DHM formation had positive effects on the ratio of 
DHM to leucine-derived products. When the ratios were calcu-
lated for the sum of leucine-derived products (HL + DHL + THL) 
compared to DHM in the individual experiments, we detected 
8.8-fold more leucine-derived products compared to DHM in the 
reference combination A1 as previously reported for this combi-
nation (Mikkelsen et al., 2010). All other combinations showed a 
more favorable ratio of DHM to chain-elongated leucine-derived 
products. The best ratios with almost equal amounts were found in 
combinations A6 and A7 (DHM:HL/DHL/THL 0.8:1) containing 
the complete set of genes and compartmenatlization (Figures 2 
and 3; Table S4 in Supplementary Material). The amounts of 
leucine-derived products remained largely unchanged through-
out our experiments. Mainly DHL and the newly detected THL 
contributed to a large extent to the high amounts of leucine-
derived products. The latter was drastically reduced in the gene 
combination including SSU1. Interestingly, we detected similar 
amounts of leucine-derived products in the combination without 
BAT5 (A4), which suggests that leucine α-keto acids are present 
and taken up by the methionine chain elongation machinery. A 
similar effect was seen in experiments without coexpression of 
BCAT4 (data not shown). Therefore, other solutions for further 
reduction of leucine-derived products may include exchange or 
mutation of single enzymes in the methionine chain elongation 
to increase affinity toward methionine and away from leucine.
In summary, our experiments provide new insights toward 
improving engineering of DHM production by transient expres-
sion in N. benthamiana. Here, we demonstrated a substantial 
30-fold increase in production of DHM (432  nmol  g−1 fw) 
compared to the highest-producing gene combination previously 
reported and a not less impressive 9-fold increase compared to the 
previously highest reported DHM production levels (Mikkelsen 
et al., 2010). Simultaneously, the amounts of leucine-derived side-
products were substantially reduced especially by re-establishing 
the compartmentalized organization of the methionine chain 
elongation in the transient expression host system. In conclu-
sion, the optimized gene combination for production of DHM 
consists of five (or six) genes: BCAT4 (BAT5), MAM1, LSU1, 
SSU1, and IPMDH1. BAT5 is only necessary if the methionine 
chain elongation is expressed in plants or other chloroplast-
containing organisms, such as microalgae, while in the case of 
a microbial host, the transport step can be omitted. Our results 
provide important insights for optimizing the engineering of 
glucoraphanin production in a heterologous host. Especially, the 
fact that the separation of the transamination step from the chain 
elongation itself improved the production of DHM mainly by 
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reducing formation of leucine-derived side-products has impli-
cations on metabolic engineering in microbial host organisms 
where such spatial separation is difficult to establish. This implies 
that other techniques might be required to create a similar level 
of spatial separation between the two parts of the chain elonga-
tion pathway. This could include creation of fusion proteins or 
coexpression of chaperons to create microenvironments that also 
could increase flux through the pathway. In addition, it should 
be considered to engineer pathway enzymes in a way to increase 
substrate specificity toward methionine and the corresponding 
intermediates. These steps should be considered before adding 
another level of complexity by engineering the core structure 
biosynthetic pathway on top of the methionine chain elongation 
pathway to ultimately create an expression system for sustainable 
production of glucoraphanin.
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